- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Which treatment modalities have better efficacy and reduced complications among patients with Cesarean scar pregnancy?
China: A recent network meta-analysis published in the American Journal of Obstetrics and Gynecology has shed light on the safety and efficacy of treatment modalities for cesarean scar pregnancy (CSP).
The findings suggested that transvaginal resection (TVR), laparoscopy (Lap), hysteroscopic curettage (Hys), and high-intensity focused ultrasound combined with suction curettage (HIFU+SC) procedures exhibited superior efficacy with reduced complications.
The researchers recommended against utilizing methotrexate (both locally guided injection and systemic administration) as a standalone medical treatment.
Cesarean scar pregnancy may lead to various complications. There are many methods for it, but no unified or recognized treatment strategies exist. Therefore, Peiying Fu, Huazhong University of Science and Technology, Wuhan, PR China, and colleagues aimed to observe the safety and efficacy of treatment modalities for CSP patients by conducting a systematic review and network meta-analysis.
For this purpose, the researchers searched the online databases from their inception to January 31, 2024. Additionally, they manually searched for relevant reviews and meta-analyses for additional references.
The study incorporated head-to-head trials involving a minimum of ten women with CSP diagnosis through ultrasound imaging, or magnetic resonance imaging (MRI), encompassing a detailed depiction of any supplementary measures and primary interventions. Trials with a Newcastle-Ottawa Scale (NOS) score below four were excluded due to the low quality.
Following a predefined protocol, group-level data on treatment safety and efficacy, study design, reproductive outcomes, and demographic characteristics were extracted. The quality of the studies was assessed using the Newcastle‒Ottawa scale (NOS) for cohort studies and case series, and Cochrane risk-of-bias tools for randomized controlled trials (RCT).
The study's main outcomes were safety (complications) and efficacy (initial treatment success), of which summary odds ratios (ORs) and the surface under the cumulative ranking curve (SUCRA) using pairwise and network meta-analysis with random effects.
The researchers reported the following findings:
- The review included seventy-three trials (7 RCTs) assessing 738369 women and 17 treatment modalities.
- Network meta-analyses were rooted in data from 7373 trials that reported success rates and 55 trials that reported complications.
- Transvaginal resection, laparoscopy, hysteroscopic curettage, and High-intensity focused ultrasound combined with suction curettage demonstrated the highest cure rates, as evidenced by SUCRA rankings of 91.2, 88.2, 86.9, and 75.3, respectively.
- Compared to suction curettage (SC), the odds ratios of efficacy were 5.92 for TVR, 6.76 for Lap, 5.00 for Hys, and 3.27 for HIFU+SC.
- Complications were more likely to occur after receiving uterine artery chemoembolization (UACE), SC, MTX+Hys, and sMTX; Hys, HIFU+SC, and Lap were safer than the other options derived from finite evidence; and the confidence intervals of all the data were wide.
In conclusion, in the study focused on the efficacy and safety of various treatment modalities for cesarean scar pregnancy, the researchers found that laparoscopy, transvaginal resection, hysteroscopic curettage, and high-intensity focused ultrasound with suction curettage emerged as the most effective interventions, with impressive success rates. Methotrexate, administered locally and systemically administered, was discouraged as a standalone medical treatment.
Reference:
Fu P, Sun H, Zhang L, Liu R. Efficacy and Safety of Treatment Modalities for Cesarean Scar Pregnancy: A Systematic Review and Network Meta-Analysis. Am J Obstet Gynecol MFM. 2024 Mar 12:101328. doi: 10.1016/j.ajogmf.2024.101328. Epub ahead of print. PMID: 38485053.
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751